AstraZeneca Pharma India gets DCGI nod for Calquence-Acalabrutinib 100mg capsules Medical Dialogues Bureau14 March 2020 6:33 AM GMTAcalabrutinib 100mg capsules are indicated for the treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).